Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DCTH

Delcath Systems Inc

16.67

Aug 10 • 3:59 PM ET +1.56 (10.32%)

16.70

Aftermarket • 4:33 PM ET +0.03 (0.18%)

Healthcare Medical Devices USA Small NASD

Aug 06, 9:48 AMDelcath beats Q2 EPS and revenue estimates with EPS $0.07 and revenue $29.1M, raises 2026 revenue guidance

Peers: ABT BSX EW MDT SYK LIVN GKOS BDX TFX BAX

| Held by: IWM VTI SURI VXF IWN VTWO IWC DFAS DFMC GSSC

Scroll to Statements

Index	RUT
Market Cap	578.43M
Enterprise Value	484.99M
Income	0.53M
Sales	95.42M
Book/sh	3.50
Cash/sh	2.76
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	156
IPO	Oct 23, 2001

P/E	2732.79
Forward P/E	-
PEG	-
P/S	6.06
P/B	4.77
P/C	6.03
P/FCF	33.03
EV/EBITDA	-
EV/Sales	5.08
Quick Ratio	8.95
Current Ratio	9.83
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	0.01
EPS next Y	-0.06
EPS next Q	-0.08
EPS this Y	-316.67%
EPS next Y	61.54%
EPS next 5Y	37.00%
EPS past 3/5Y	- -
Sales past 3/5Y	215.30% 120.21%
EPS Y/Y TTM	-76.27%
Sales Y/Y TTM	35.85%
EPS Q/Q	0.15%
Sales Q/Q	20.60%
Earnings	Aug 06 BMO
EPS/Sales Surpr.	178.56% 10.97%

Insider Own	7.58%
Insider Trans	0.21%
Inst Own	50.01%
Inst Trans	-1.10%
ROA	0.42%
ROE	0.47%
ROIC	0.43%
Gross Margin	87.05%
Oper. Margin	-1.90%
Profit Margin	0.56%
SMA20	28.26%
SMA50	34.38%
SMA200	57.99%
Trades

Shs Outstand	34.64M
Shs Float	32.07M
Short Float	8.40%
Short Ratio	5.03
Short Interest	2.69M
52W High	16.38 1.80%
52W Low	8.12 105.30%
Volatility	7.14% 4.91%
ATR (14)	0.84
RSI (14)	75.19
Beta	0.57
Rel Volume	2.69
Avg Volume	535.39K
Volume	1,441,856

Perf Week	27.84%
Perf Month	28.13%
Perf Quarter	45.21%
Perf Half Y	77.91%
Perf YTD	65.05%
Perf Year	66.53%
Perf 3Y	416.10%
Perf 5Y	70.10%
Perf 10Y	-100.00%
Recom	1.00
Target Price	24.50
Prev Close	15.11
Price	16.67
Change %	10.32%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Initiated	Craig Hallum	Buy	$18
May-14-24	Initiated	Stephens	Overweight	$25
Jul-26-22	Resumed	Canaccord Genuity	Buy	$17
Dec-10-21	Initiated	H.C. Wainwright	Buy	$25
Mar-09-21	Initiated	Canaccord Genuity	Buy	$24
Jan-05-21	Initiated	BTIG Research	Buy	$23
Jun-01-20	Initiated	Laidlaw	Buy	$19

Aug-06-26 01:49PM	These Two Stocks Hit Fresh 52-Week Highs Today DCTH Clocks Best Day In Nearly 15 Months (Stocktwits) +22.49%
08:01AM	Delcath Systems Reports Second Quarter 2026 Results and Business Highlights (Business Wire)
Jul-28-26 04:01PM	Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference (Business Wire)
Jul-23-26 04:01PM	Delcath Systems to Host Second Quarter 2026 Earnings Call (Business Wire)
Jul-16-26 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
04:01PM	Loading…
May-26-26 04:01PM	Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts (Business Wire)
May-15-26 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-12-26 08:00AM	Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference (Business Wire)
May-08-26 08:30AM	Delcath Systems, Inc. Q1 2026 Earnings Call Summary (Moby)
May-07-26 08:00AM	Delcath Systems Reports First Quarter 2026 Results and Business Highlights (Business Wire)
07:00AM	Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 (Business Wire)
Apr-23-26 08:30AM	Delcath Systems to Host First Quarter 2026 Earnings Call (Business Wire)
Apr-06-26 08:30AM	Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO-EURACAN Clinical Practice Guidelines for Uveal Melanoma (Business Wire)
Apr-01-26 08:30AM	Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting (Business Wire)
Mar-04-26 08:43AM	Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology (TipRanks) +7.33%
08:00AM	Loading…
Mar-03-26 08:00AM	Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology (Business Wire)
Feb-26-26 04:09PM	Delcath Systems Inc (DCTH) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -11.85%
03:48PM	Delcath Systems Q4 Earnings Call Highlights (MarketBeat)
08:30AM	Delcath Systems, Inc. Q4 2025 Earnings Call Summary (Moby)
08:00AM	Delcath Systems Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-12-26 08:00AM	Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call (Business Wire)
Feb-11-26 03:15PM	Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating (Insider Monkey) -5.94%
Jan-27-26 08:05AM	Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-21-26 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.19%
Jan-09-26 08:05AM	Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Jan-02-26 08:38AM	Are Options Traders Betting on a Big Move in Delcath Systems Stock? (Zacks)
Jan-01-26 08:15AM	Delcath Systems publishes results from subgroup analyses of FOCUS study (TipRanks)
Dec-31-25 08:00AM	Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma (Business Wire)
Dec-16-25 10:25AM	Here's What Hit Delcath Systems (DCTH) in Q3 (Insider Monkey)
Dec-03-25 04:01PM	Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma (Business Wire)
08:36AM	Loading…
Nov-24-25 08:36AM	Do Options Traders Know Something About Delcath Systems Stock We Don't? (Zacks)
Nov-20-25 04:01PM	Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program (Business Wire) +9.40%
Nov-18-25 08:00AM	Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma (Business Wire)
05:07AM	H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT (Insider Monkey)
Nov-14-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-13-25 08:30AM	Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients (Business Wire)
Nov-06-25 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Nov-04-25 04:06PM	Delcath Systems Inc (DCTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:15AM	Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates (Zacks)
08:00AM	Delcath Systems Reports Third Quarter 2025 Results and Business Highlights (Business Wire)
Oct-27-25 04:43PM	Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. (Barrons.com)
Oct-21-25 08:30AM	Delcath Systems to Host Third Quarter 2025 Earnings Call (Business Wire)
Oct-18-25 04:15PM	Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results (Business Wire)
04:13PM	Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint (Business Wire)
Sep-22-25 04:01PM	Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress (Business Wire)
Sep-05-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-04-25 02:52PM	Invesco Backs Delcath Systems (DCTH) on Expansion Potential (Insider Monkey)
Aug-21-25 08:30AM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Aug-19-25 08:30AM	Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer (Business Wire)
Aug-13-25 12:08PM	H.C. Wainwright Remains Bullish on Delcath Systems (DCTH) (Insider Monkey)
Aug-06-25 09:15AM	Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
08:00AM	Delcath Systems Reports Second Quarter 2025 Results and Business Highlights (Business Wire)
Jul-29-25 04:01PM	Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-28-25 05:15PM	Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-25-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-23-25 04:01PM	Delcath Systems to Host Second Quarter 2025 Earnings Call (Business Wire)
Jul-17-25 08:32AM	Is the Options Market Predicting a Spike in Delcath Systems Stock? (Zacks)
Jun-04-25 12:00PM	Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know (Zacks)
09:40AM	Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? (Zacks)
May-28-25 09:55AM	Wall Street Analysts Predict a 48.69% Upside in Delcath Systems (DCTH): Here's What You Should Know (Zacks)
08:50AM	Here's Why Momentum in Delcath Systems (DCTH) Should Keep going (Zacks)
May-22-25 07:00AM	Delcath Systems Issues Full Year 2025 Guidance (Business Wire) -6.32%
May-15-25 04:30PM	Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference (Business Wire) +6.54%
May-09-25 05:30PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
03:15AM	Delcath Systems Inc (DCTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-25 08:45AM	Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates (Zacks) +23.64%
07:30AM	Delcath Systems Reports First Quarter 2025 Results and Business Highlights (Business Wire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
02:21PM	Delcath Systems Q1 2025 Earnings Preview (Seeking Alpha)
May-06-25 07:10AM	Waters (WAT) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-28-25 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer (Business Wire)
Apr-27-25 09:22AM	Immunocore Holdings: A Name On My Watch List (Seeking Alpha)
Apr-24-25 04:01PM	Delcath Systems to Host First Quarter 2025 Earnings Call (Business Wire)
Apr-10-25 09:03AM	Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? (Zacks) -7.71%
Apr-09-25 05:00PM	Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma (Business Wire) +9.82%
Apr-02-25 11:49AM	Hospitals Experience FOMO In Adopting Delcath's PHP Treatment (Seeking Alpha)
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
10:46AM	Jim Cramer Blesses Delcath Systems (DCTH): 'You're Not Early, But It's a Win' (InsiderMonkey)
Mar-26-25 09:55AM	Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? (Zacks) -6.52%
Mar-24-25 04:01PM	Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Mar-19-25 09:40AM	Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-14-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-06-25 08:00AM	Delcath Systems Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-20-25 08:30AM	Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call (Business Wire)
Feb-14-25 08:30AM	Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma (Business Wire)
Jan-31-25 07:00AM	Biotech walks a 'tightrope' amid unclear funding, regulations (Yahoo Finance Video)
Jan-28-25 04:01PM	Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-15-25 02:31PM	Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
Jan-13-25 08:00AM	Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results (Business Wire) +11.41%
Jan-03-25 04:01PM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-30-24 08:00AM	Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises (Business Wire)
Dec-02-24 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer (Business Wire) +6.40%
Nov-09-24 04:00PM	Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-08-24 08:00AM	Delcath Systems Reports Third Quarter 2024 Results and Business Highlights (Business Wire)
Nov-01-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-24 08:30AM	Delcath Systems to Host Third Quarter 2024 Earnings Call (Business Wire)
Oct-17-24 08:30AM	Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results (Business Wire) +7.57%
Sep-20-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-16-24 08:30AM	Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT in Metastatic Uveal Melanoma Subgroups (Business Wire)
Aug-28-24 04:01PM	Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients (Business Wire)

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

MSMr. Gerard J. Michel MBA

Chief Operating OfficerDr. Martha S. Rook Ph.D.

M.Sc.Dr. Vojislav Vukovic M.D.

Chief Financial OfficerMs. Sandra Pennell CPA

General CounselMr. David Hoffman J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pennell Sandra	Chief Financial Officer	Mar 06 '26	Buy	9.04	5,533	50,018	77,018	Mar 06 04:22 PM
Sylvester John Richard	Director	Nov 21 '25	Buy	8.89	4,386	38,992	14,936	Nov 25 04:15 PM
MICHEL GERARD J	CHIEF EXECUTIVE OFFICER	Nov 11 '25	Buy	8.53	11,500	98,049	330,834	Nov 13 11:53 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DCTH

Delcath Systems Inc

Upgrade your Finviz experience